Ameritas Advisory Services’s Pfizer PFE Stock Holding History

Ameritas Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Sell	88,492 -11,176	-11%	-$292K	0.04%	350
2026 Q1	$2.8M	Sell	99,668 -28,201	-22%	-$751K	0.11%	178
2025 Q4	$3.18M	Buy	127,869 +90,384	+241%	+$2.28M	0.12%	162
2025 Q3	$955K	Sell	37,485 -12,826	-25%	-$317K	0.06%	259
2025 Q2	$1.22M	Sell	50,311 -26,646	-35%	-$621K	0.06%	299
2025 Q1	$1.98M	Buy	76,957 +974	+1%	+$25.5K	0.08%	239
2024 Q4	$2.02M	Buy	75,983 +2,633	+4%	+$71.4K	0.07%	257
2024 Q3	$2.12M	Sell	73,350 -7,023	-9%	-$205K	0.09%	216
2024 Q2	$2.25M	Sell	80,373 -3,160	-4%	-$87K	0.08%	229
2024 Q1	$2.32M	Buy	83,533 +34,064	+69%	+$945K	0.1%	209
2023 Q4	$1.41M	Sell	49,469 -53,002	-52%	-$1.6M	0.08%	226
2023 Q3	$3.33M	Buy	102,471 +66,796	+187%	+$2.36M	0.17%	123
2023 Q2	$1.27M	Sell	35,675 -74,406	-68%	-$2.9M	0.16%	145
2023 Q1	$4.43M	Sell	110,081 -18,760	-15%	-$810K	0.22%	92
2022 Q4	$6.6M	Buy	128,841 +8,207	+7%	+$393K	0.31%	76
2022 Q3	$5.28M	Sell	120,634 -1,869	-2%	-$90.8K	0.32%	68
2022 Q2	$6.42M	Buy	122,503 +4,151	+4%	+$212K	0.37%	54
2022 Q1	$6.13M	Buy	118,352 +4,959	+4%	+$257K	0.22%	73
2021 Q4	$6.7M	Buy	+113,393	New	+$5.62M	0.24%	76

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ameritas Advisory Services's PFE Position: Q2 2026 in Review

Ameritas Advisory Services reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $292K and leaving 88,492 shares worth $2.13M. The position accounts for 0.04% of the portfolio, ranked #350.

Ameritas Advisory Services first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.7M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ameritas Advisory Services held 88,492 shares of Pfizer worth $2.13M as of Q2 2026.
Ameritas Advisory Services sold 11,176 Pfizer shares in Q2 2026, an estimated $292K.
Pfizer made up 0.04% of Ameritas Advisory Services's portfolio in Q2 2026, its #350 holding.
Ameritas Advisory Services first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
Ameritas Advisory Services's Pfizer position peaked at $6.7M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.